Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer
08. Mai 2024 09:00 ET
|
Coherus BioSciences, Inc.
REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus; Nasdaq: CHRS) today announced that the Cancer Research Institute (CRI) and its Immunotherapy Platform Study...
Expert Roundtable Explores Recent Advances in Cancer Immunotherapy
30. Juni 2011 08:00 ET
|
MD Becker Partners LLC
NEW YORK, June 30, 2011 (GLOBE NEWSWIRE) -- The Cancer Research Institute (CRI) and MD Becker Partners announced today the release of a joint report titled, "Cancer Immunotherapy: A Roundtable...